Now on Spilling Secrets, our podcast series on the future of non-compete and trade secret law: Human capital often drives the value of merger and acquisition (M&A) deals in the health care industry. Buyers involved in these deals must retain key employees to secure that value. Epstein Becker Green’s Spilling Secrets hosts Erik W. Weibust and Katherine G. Rigby join forces with the Healthcare Diagnostics podcast hosts Daniel L. Fahey and Timothy J. Murphy to talk about strategies to retain these employees.* * * Tune in to Spilling Secrets, a podcast series on the future of trade secrets and non-compete law.…
Category: Law Firm
2023-04-19 | Press Release | ROSEN, A LONGSTANDING LAW FIRM, Encourages Hesai Group Investors to Secure Counsel Before Important Deadline in First Filed Securities Class Action Commenced by the Firm
NEW YORK, April 19, 2023 /PRNewswire/ —WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Hesai Group (NASDAQ: HSAI) pursuant and/or traceable to the Company’s initial public offering conducted in February 2023 (the “IPO”), of the important June 6, 2023 lead plaintiff deadline in the securities class action commenced by the Firm. SO WHAT: If you purchased Hesai securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Hesai class action, go to https://rosenlegal.com/submit-form/?case_id=13347…
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmThe Schall Law Firm, a national shareholder rights litigation firm, announced that it is investigating claims on behalf of investors of Chinook Therapeutics, Inc. (“Chinook” or “the Company”) (NASDAQ: KDNY) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Chinook is the subject of a report issued by Muddy Waters Research on May 16, 2023. According to the report, the Company’s lead product candidate “has been shown to be harmful to patients’ cardiovascular health”, and that “AbbVie and Chinook appear to have systemically manipulated research findings and presentation on atrasentan to obscure these trial results.”…
2023-04-19 | NYSE:UP | Press Release
NEW YORK, April 19, 2023 /PRNewswire/ —WHY: Rosen Law Firm, a global investor rights law firm, announced it has filed a class action lawsuit on behalf of purchasers of the securities of Wheels Up Experience Inc. (NYSE:UP) between November 9, 2022 and March 31, 2023, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move to Court no later than June 19, 2023. SO WHAT: If you purchased Wheels Up securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.…
Lawyers win big in $787.5 million Fox defamation case
By Andrew Goudsward (Reuters) – The $787.5 million settlement that ended Dominion Voting Systems’ defamation lawsuit against Fox Corp also marks the end of a lucrative, two-year legal battle for the sprawling teams of highly-paid lawyers on both sides. At least 31 lawyers from nine different law firms worked on the case, court filings show. Dominion said Fox News broadcast false claims that the company’s voting machines were involved in a conspiracy to rig the 2020 US presidential election, and won one of the biggest settlements paid in a defamation lawsuit. Delaware Superior Court Judge Eric Davis complimented the legal teams in court after Tuesday’s settlement, saying he had not seen “as good of lawyering” in 13 years on the bench.…
Epstein Becker Green Launches 50-State Noncompete Survey for Employers
Epstein Becker Green (EBG) is pleased to announce the launch of our 50-State Noncompete Survey, designed to give employers a desktop guide to the great variety and specificity of noncompete laws across the United States. EBG’s 50-State Noncompete Survey is here to help provide key insights on all of the following areas of noncompete law in your state:Are non-competitive employees permissible? Is there a general non-compete statute or other industry-specific statute and rules? Are certain employees exempt from noncompetitive? Is continued employment sufficient consideration? Are there notice-related or other unique requirements? Are customers and employees non-solvent permissible? Can noncompetes be enforced against terminated employees?…
Berger Montague PC Expands Internationally by Opening Office in Toronto, Canada
TORONTO, April 19, 2023 /CNW/ — Berger Montague, a leading plaintiffs’ class action and commercial litigation law firm, is expanding internationally with the opening of an office in Toronto, Ont., Canada. The Firm is headquartered in the United States in Philadelphia, Pennsylvania with additional law offices in Minneapolis, Washington, D.C, Chicago, San Diegoand San Francisco. Berger Montague Canada will be a full-service civil litigation, class action, and commercial litigation law firm with a particular focus on securities and antitrust litigation. Berger Montague Canada will represent, among other prominent clients, institutional and retail investors, as well as shareholders in disputes relating to investments in Canadian companies that list their securities on Canadian, European, and US stock exchanges.…
The Gross Law Firm Reminds Shareholders
NEW YORK, April 20, 2023 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Amgen Inc. Shareholders who purchased shares of AMGN during the class listed period are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE:Amgen Inc. Loss Submission FormPERIOD CLASS: This lawsuit is on behalf of all persons who purchased or otherwise acquired Amgen common stock between July 29, 2020 and April 27, 2022, inclusive. ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (a) the US government claimed Amgen owed more than $3 billion in back taxes for tax years 2010, 2011, and 2012; (b) the US government claimed Amgen owed more than $5 billion in back taxes for tax years 2013, 2014, and 2015; (c) the US government would likely claim Amgen owed materially more to the US government than investors had been led to believe for subsequent tax years for which the Company had used the same profit allocation treatment between its US and Puerto Rico operations; (d) Amgen had not taken sufficient accruals to account for its outstanding tax liabilities; (e) Amgen had failed to comply with Accounting Standards Codification Topic 450 and other rules and regulations regarding the preparation of its periodic filings with the US Securities and Exchange Commission; and (f) Amgen’s refusal to pay taxes claimed by the US government exposed the Company to a substantial risk of severe financial penalties imposed by the Internal Revenue Service.…